NEW YORK (360Dx) – Biofortuna, a UK-based contract in vitro diagnostics development, freeze drying, and stabilization services provider, announced this week a new investment into and an expansion of its IVD service portfolio. The expansion will allow the firm to place a greater focus on immunoassay design, development, and manufacturing. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.